South Korea: Revealing the path of lung injury in patients with neo-crown pneumonia
-
Last Update: 2021-02-22
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
a South Korean study has found that cytokine storms in patients with neocyto pneumonia are a protein involved in lipid synthesis, south Korea's East Asia Science website reported. Out-of-control cytokine storms cause lung damage in patients.The Korea Institute of Life Engineering recently published the results. A joint study led by Xu Ying-chun, a senior researcher in the Institute's Special Research Group on Aging Artificial Intervention, and a team at Lingnan University in South Korea and Gyeon North University in South Korea found that the steroid regulator binding protein (SREBP), a key transcription factor that controls lipid synthesis in the human body, was involved in a cytokine storm in patients with new pneumonia crowns.The team studied the activity levels of the transcription factor in the blood of patients with neocycline pneumonia to clarify this path. Targeting the binding protein of steroid regulatory elements is expected to find a new direction for diagnosis and treatment of patients with neo-coronary pneumonia.Clinical data show that about 15% to 20% of patients with neo-crown pneumonia may develop severe pneumonia, of which about 5% may develop acute respiratory distress. Respiratory failure is the leading cause of death in patients with neo-coronary pneumonia.Previous studies have confirmed that inflammatory cytokine storm response is highly related to the severity of neocyto pneumonia symptoms and patient mortality. Patients with severe neo-coronary pneumonia are more likely to have cytokine storm syndrome (Cytokine storm syndrome, CSS) that triggers an out-of-control inflammatory response that can lead to shock, organ damage and even organ failure. Finding the deep mechanism of cytokine storm response in patients with neocyto pneumonia is considered a key step in the treatment of neocyto pneumonia. (Science and Technology Daily)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.